苏州壹达生物科技有限公司是一家专业电转染仪研发生产商，其核心团队由国内多学科、多领域的12名精英组成， 其中有6名博士，包括2名国家特聘‘千人计划’和4名高校教授，在小核酸制药、微电子学与MEMS、细胞免疫治疗、健康美容和国内国际营销领域均有成。壹达生物科技在细胞电转染领域拥有自主知识产权，其中发明专利14项（9项已授权、5项申请中）、实用新型专利6项（4项已授权、2项申请中），并拥有3项PCT专利申请，其中3项已申请进入美国和欧盟。壹达细胞电转染仪填补国内电转染设备领域的空白，并以其高转染效率、高细胞成活率、超高转染通量等优越性能赢得客户和市场。壹达现在制造销售的产品为科研用电转染仪X-Porator H1, 高单次处理量可达3ml。2017年下半年将推出流式电转仪，高处理量可达250ml ,可用于科研，抗体药物生产和细胞免疫治疗研究（创新医疗器械注册证申请中）。Etta Biotech Co., Ltd. has a founding team of 12 members with a wide range of research and business backgrounds such as RNA pharmaceutics, microelectronics, MEMS, immunotherapy, cosmetic and marketing. 6 of them possess a Ph.D degree, 2 of them are National 1000-Plan Experts and 4 are professors from top universities.Etta Biotech possesses an intellectual property portfolio including 14 invention patents (9 of them having been authorized and 5 of them being applied), 6 utility model patents (4 of them having been authorized and 2 of them being applied), and 3 PCT patent applications, of which 3 have been applied for US and EU patents.Etta Biotech is a Chinese company specialized in R&D of electroporation technology and products. Its cell electroporation system X-Porator H1 was launched in August 2015 and has won customers with its excellent performance such as high transfection efficiency, high cell survival rate, high single transfection volume (up to 3ml) etc. In the second-half of 2017, Etta Biotech will launch a new series of electroporator product, the flow electroporator X-Porator F with a maximum single treatment volume of up to 250ml, which would meet transfection needs in scientific research, antibody drug production and cell immunotherapy of cancer.
